Suppr超能文献

Chemerin 位于血管壁中,有助于维持血管张力。

Chemerin is resident to vascular tunicas and contributes to vascular tone.

机构信息

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.

Transgenic and Genome Editing Facility, Research Technology Support Facility, and Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, United States.

出版信息

Am J Physiol Heart Circ Physiol. 2023 Jul 1;325(1):H172-H186. doi: 10.1152/ajpheart.00239.2023. Epub 2023 Jun 9.

Abstract

The adipokine chemerin may support blood pressure, evidenced by a fall in mean arterial pressure after whole body antisense oligonucleotide (ASO)-mediated knockdown of chemerin protein in rat models of normal and elevated blood pressure. Although the liver is the greatest contributor of circulating chemerin, liver-specific ASOs that abolished hepatic-derived chemerin did not change blood pressure. Thus, other sites must produce the chemerin that supports blood pressure. We hypothesize that the vasculature is a source of chemerin independent of the liver that supports arterial tone. RNAScope, PCR, Western blot analyses, ASOs, isometric contractility, and radiotelemetry were used in the Dahl salt-sensitive (SS) rat (male and female) on a normal diet. Retinoic acid receptor responder 2 () mRNA was detected in the smooth muscle, adventitia, and perivascular adipose tissue of the thoracic aorta. Chemerin protein was detected immunohistochemically in the endothelium, smooth muscle cells, adventitia, and perivascular adipose tissue. Chemerin colocalized with the vascular smooth muscle marker α-actin and the adipocyte marker perilipin. Importantly, chemerin protein in the thoracic aorta was not reduced when liver-derived chemerin was abolished by a liver-specific ASO against chemerin. Chemerin protein was similarly absent in arteries from a newly created global chemerin knockout in Dahl SS rats. Inhibition of the receptor Chemerin1 by the receptor antagonist CCX832 resulted in the loss of vascular tone that supports potential contributions of chemerin by both perivascular adipose tissue and the media. These data suggest that vessel-derived chemerin may support vascular tone locally through constitutive activation of Chemerin1. This posits chemerin as a potential therapeutic target in blood pressure regulation. Vascular tunicas synthesizing chemerin is a new finding. Vascular chemerin is independent of hepatic-derived chemerin. Vasculature from both males and females have resident chemerin. Chemerin1 receptor activity supports vascular tone.

摘要

脂肪因子趋化素可能有助于维持血压,这一点在正常和高血压大鼠模型中得到了证实,即在全身反义寡核苷酸(ASO)介导的趋化蛋白敲低后,平均动脉压下降。虽然肝脏是循环趋化素的最大贡献者,但消除肝源性趋化素的肝特异性 ASO 并未改变血压。因此,其他部位必须产生支持血压的趋化素。我们假设血管是一种独立于肝脏的趋化素来源,它支持动脉张力。在正常饮食的 Dahl 盐敏感(SS)大鼠(雄性和雌性)中使用了 RNAScope、PCR、Western blot 分析、ASO、等长收缩性和无线电遥测技术。在胸主动脉的平滑肌、外膜和血管周围脂肪组织中检测到维甲酸受体应答 2()mRNA。免疫组织化学检测到趋化素蛋白在内皮细胞、平滑肌细胞、外膜和血管周围脂肪组织中表达。趋化素与血管平滑肌标志物α-肌动蛋白和脂肪细胞标志物 perilipin 共定位。重要的是,当通过针对趋化素的肝特异性 ASO 消除肝源性趋化素时,胸主动脉中的趋化素蛋白并未减少。在 Dahl SS 大鼠中创建的新的全局趋化素敲除的动脉中,也同样缺乏趋化素蛋白。趋化素受体 Chemerin1 的抑制剂 CCX832 导致支持血管张力的丧失,这可能是血管周围脂肪组织和中膜趋化素的潜在贡献。这些数据表明,血管源性趋化素可能通过血管周围脂肪组织和中膜的组成性激活 Chemerin1 来支持局部血管张力。这表明趋化素可能是血压调节的潜在治疗靶点。血管外膜合成趋化素是一个新的发现。血管趋化素独立于肝源性趋化素。来自男性和女性的血管都有常驻趋化素。Chemerin1 受体活性支持血管张力。

相似文献

1
Chemerin is resident to vascular tunicas and contributes to vascular tone.
Am J Physiol Heart Circ Physiol. 2023 Jul 1;325(1):H172-H186. doi: 10.1152/ajpheart.00239.2023. Epub 2023 Jun 9.
2
Vascular chemerin from PVAT contributes to norepinephrine and serotonin-induced vasoconstriction and vascular stiffness in a sex-dependent manner.
Am J Physiol Heart Circ Physiol. 2024 Dec 1;327(6):H1577-H1589. doi: 10.1152/ajpheart.00475.2024. Epub 2024 Oct 25.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Antisense Oligonucleotide Targeting Sortilin Reduces Vascular Calcification in Mice in a Sex-Dependent Manner.
Arterioscler Thromb Vasc Biol. 2025 Aug;45(8):1398-1415. doi: 10.1161/ATVBAHA.124.321999. Epub 2025 Jun 12.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Vascular effects of perivascular adipose tissue-derived chemerin in obesity-associated cardiovascular disease.
Cardiovasc Diabetol. 2025 Jun 13;24(1):249. doi: 10.1186/s12933-025-02814-5.
2
Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia.
Hypertension. 2024 Apr;81(4):861-875. doi: 10.1161/HYPERTENSIONAHA.123.22457. Epub 2024 Feb 15.
3
Novel role of vascular chemerin in blood vessel tone.
Am J Physiol Heart Circ Physiol. 2023 Aug 1;325(2):H321-H322. doi: 10.1152/ajpheart.00395.2023. Epub 2023 Jul 7.

本文引用的文献

1
Chemerin Forms: Their Generation and Activity.
Biomedicines. 2022 Aug 19;10(8):2018. doi: 10.3390/biomedicines10082018.
3
Chemerin regulates normal angiogenesis and hypoxia-driven neovascularization.
Angiogenesis. 2022 May;25(2):159-179. doi: 10.1007/s10456-021-09818-1. Epub 2021 Sep 15.
4
Chemerin promotes the pathogenesis of preeclampsia by activating CMKLR1/p-Akt/CEBPɑ axis and inducing M1 macrophage polarization.
Cell Biol Toxicol. 2022 Aug;38(4):611-628. doi: 10.1007/s10565-021-09636-7. Epub 2021 Aug 16.
6
Circulating chemerin level is associated with metabolic, biochemical and haematological parameters-A population-based study.
Clin Endocrinol (Oxf). 2021 Jun;94(6):927-939. doi: 10.1111/cen.14441. Epub 2021 Feb 23.
8
Chemerin as a Driver of Hypertension: A Consideration.
Am J Hypertens. 2020 Nov 3;33(11):975-986. doi: 10.1093/ajh/hpaa084.
9
Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions.
Physiol Genomics. 2019 Nov 1;51(11):553-561. doi: 10.1152/physiolgenomics.00050.2019. Epub 2019 Oct 7.
10
Body Fat Distribution and Systolic Blood Pressure in 10,000 Adults with Whole-Body Imaging: UK Biobank and Oxford BioBank.
Obesity (Silver Spring). 2019 Jul;27(7):1200-1206. doi: 10.1002/oby.22509. Epub 2019 May 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验